« Return to News | R&D Trends

PharmaNet, McGill to develop Canadian translational research facility

Thursday, September 15, 2011 10:52 AM

PharmaNet Development Group, the US-based clinical development services provider acquired by inVentiv Health, has teamed up with a Canadian research institute to set up what the company says will be the country’s first in-hospital translational medicine unit for phase I-IIa clinical trials, according to PharmaTimes.

PharmaNet’s local subsidiary, PharmaNet Canada, has signed a letter of intent with The Research Institute of McGill University Health Centre (RI MUHC) in Montreal for a joint venture to establish, manage and operate the facility at the Montreal General Hospital.

The translational medicine unit, which PharmaNet says will “transform” the way pivotal proof-of-concept studies are conducted, is expected to start operations in 2012. According to Riaz Bandali, president, early stage development for PharmaNet, the initiative “aligns PharmaNet’s and RI MUHC’s objectives of optimally developing innovative therapeutics for patients in need.”

Pharmaceutical and biopharmaceutical companies using the facility will have access to state-of-the-art capabilities, specialized scientific knowledge, a broad range of patients, and “unsurpassed” medical and clinical development expertise within a safe hospital environment, Bandali added.

RI MUHC director Dr Vassilios Papadopoulos cited the Institute’s medical and scientific leadership in the understanding of diseases such as cancer, respiratory illness and cardiovascular failure.  

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.